ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Stephen R. Hazelrigg
Ibrahim B. Cetindag
Jacquelyn A. Quin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hazelrigg, S. R.
Right arrow Articles by Verhulst, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hazelrigg, S. R.
Right arrow Articles by Verhulst, S.
Related Collections
Right arrow Electrophysiology - arrhythmias

Ann Thorac Surg 2004;77:824-830
© 2004 The Society of Thoracic Surgeons


Original article: cardiovascular

The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting

Stephen R. Hazelrigg, MDa*, Theresa M. Boley, MSNa, Ibrahim B. Cetindag, MDa, Kreigh P. Moulton, MDb, Gary L. Trammell, PhDc, Joan E. Polancic, PhDc, Tilitha S. Shawgo, MSNa, Jacquelyn A. Quin, MDa, Stephen Verhulst, PhDa

a Southern Illinois University School of Medicine, Springfield, IL, USA
b Prairie Cardiovascular Consultants, Springfield, IL, USA
c University of Illinois–Springfield, Springfield, Illinois, USA

Accepted for publication August 21, 2003.

* Address reprint requests to Dr Hazelrigg, Division of Cardiothoracic Surgery, SIU School of Medicine, 800 N. Rutledge, Room D319, PO Box 19638, Springfield, IL 62794-9638, USA.
e-mail: shazelrigg{at}siumed.edu

BACKGROUND: Atrial fibrillation after coronary artery bypass is reported from 17% to 53%. Hypomagnesemia after this surgery is considered a contributing factor.

METHODS: Two hundred-two coronary bypass patients were randomized to magnesium (n = 105) or placebo (n = 97). The experimental group received 80-mg magnesium sulfate per kilogram ideal weight in 100 mL dextrose 5% water 30 minutes preoperatively. Postoperatively, patients received 8-mg magnesium sulfate per kilogram ideal weight intravenous per hour more than 48 hours. The control group received dextrose 5% water at these intervals.

RESULTS: After the first bolus serum magnesium was experimental 4.75 mg/dL versus control 1.91 mg/dL, p less than 0.001, and remained different until postoperative day 4 (experimental 2.33 mg/dL vs control 2.26 mg/dL, p = 0.24). Atrial appendage and strap muscle were analyzed after the first bolus and after revascularization. There were no differences between groups in tissue magnesium or calcium. Urinary magnesium was elevated in the experimental (experimental 324.5 mg/24 hours, vs control 45.1 mg/24 hours, p = 0.01). Calcium excretion was higher (experimental 370 mg/24 hours vs control 186 mg/24 hours, p < 0.001) and was associated with lower serum calcium. Serum calcium was higher in the control through the fourth postoperative day. The incidence of atrial fibrillation was experimental 32 of 105 (30.5%) versus control 41 of 97 (42.3%) p = 0.08. Atrial fibrillation was different on the first postoperative day (experimental 3/105, 2.9% vs control 9/97, 9.3%), p = 0.05.

CONCLUSIONS: Overall prophylactic magnesium supplementation does not significantly reduce atrial and ventricular arrhythmias. The only significant benefit of magnesium supplementation was on the first postoperative day.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Dunning, T. Treasure, M. Versteegh, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 852 - 872.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. C. Burgess, M. J. Kilborn, and A. C. Keech
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis
Eur. Heart J., December 1, 2006; 27(23): 2846 - 2857.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. N. Henyan, E. L. Gillespie, C. M. White, J. Kluger, and C. I. Coleman
Impact of Intravenous Magnesium on Post-Cardiothoracic Surgery Atrial Fibrillation and Length of Hospital Stay: A Meta-Analysis
Ann. Thorac. Surg., December 1, 2005; 80(6): 2402 - 2406.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Jones
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1517 - 1528.
[Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
G. Maiocco
Review: magnesium prophylaxis after cardiac surgery reduces the risk of arrhythmia and atrial fibrillation
Evid. Based Nurs., April 1, 2005; 8(2): 55 - 55.
[Full Text] [PDF]


Home page
ICVTSHome page
A. Rostron, A. Sanni, and J. Dunning
Does magnesium prophylaxis reduce the incidence of atrial fibrillation following coronary bypass surgery?
Interactive CardioVascular and Thoracic Surgery, February 1, 2005; 4(1): 52 - 58.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.